Matthew E. Ros
Chief Operating Officer · Jasper Therapeutics, Inc.
- 2026
- Jul 22, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew E. Ros files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Patrick J. Crutcher - JSPR
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew E. Ros?
Matthew E. Ros is a corporate insider, tracked as Chief Operating Officer of Jasper Therapeutics, Inc. (JSPR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matthew E. Ros submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Matthew E. Ros been buying or selling stock?
Recorded transactions: 1 open-market purchase and 0 open-market sales across all tracked filings.